World Leader in

Cell Expansion & Rejuvenation

What
We do

EnhanceTM
Platform

Proprietary hematopoietic stem cell (HSC) expansion and rejuvenation platform

Learn more

UM171 Cell
Therapy

Allogeneic stem cell therapy to treat blood cancers

Learn more

Pipeline

Pre-clinical pipeline for blood cancers and other diseases

Learn more

News

June 25, 2024

ExCellThera announces EMA’s acceptance under Accelerated Assessment of Market Authorisation Application (MAA) for UM171 Cell Therapy for patients with hematological malignancies who lack a readily available suitable donor

Market Authorisation Application (MAA) for UM171 Cell Therapy accepted under an accelerated assessment procedure by the European Medicines Agency (EMA), for adult patients with hematological malignancies requiring a stem cell transplant who lack a readily available suitable donor MONTREAL, June 25, 2024 – ExCellThera Inc. (ExCellThera), a world leader in enhanced blood stem cell expansion and […]

Read more
See all articles

About us

Who we are

ExCellThera is an advanced clinical-stage company specializing in cell expansion and engineering, providing molecules and bioengineering solutions to expand and modify various cell lines for use in innovative single-use curative therapies for patients with hematological malignancies and other diseases.

Learn more
Symbol